HDAC9 and cancer: Collectively, HDAC inhibition contributes to antigen processing and tumor cell recognition, which in turn activates immune cell cytotoxicity and serves as a potential pre-treatment approach for adoptive immune cell therapy to efficiently eliminate cancer cells.